Tsfg, LLC Biogen Inc. Transaction History

Tsfg, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 23, 2024	SELL	$222.59 - $267.94 $890 - $1,071	-4 Reduced 44.44%	5 $1,000
Q2 2023 Jul 10, 2023	BUY	$275.25 - $318.06 $550 - $636	2 Added 28.57%	9 $3,000
Q3 2022 Oct 20, 2022	SELL	$194.69 - $268.46 $7,203 - $9,933	-37 Reduced 84.09%	7 $2,000
Q4 2021 Feb 10, 2022	BUY	$223.92 - $287.77 $8,732 - $11,223	39 Added 780.0%	44 $11,000
Q3 2019 Jan 27, 2020	SELL	$217.44 - $243.88 $10,872 - $12,194	-50 Reduced 90.91%	5 $1,000
Q1 2019 Jan 27, 2020	BUY	$216.71 - $338.96 $11,919 - $18,642	55 New	55 $13,000

1,032

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Tsfg, LLC, based on Form 13F filings with the SEC.

Stay updated on Tsfg, LLC with notifications on news.